25. Vigilance of Alternatives for Blood Components

  1. René R. P. De Vries MD2 and
  2. Jean-Claude Faber MD3
  1. Dafydd Thomas MBChB, FRCA

Published Online: 6 AUG 2012

DOI: 10.1002/9781118338179.ch25

Hemovigilance: An Effective Tool for Improving Transfusion Safety

Hemovigilance: An Effective Tool for Improving Transfusion Safety

How to Cite

Thomas, D. (2012) Vigilance of Alternatives for Blood Components, in Hemovigilance: An Effective Tool for Improving Transfusion Safety (eds R. R. P. De Vries and J.-C. Faber), Wiley-Blackwell, Oxford, UK. doi: 10.1002/9781118338179.ch25

Editor Information

  1. 2

    Department of Immunohematology and Blood Transfusion, Leiden University Medical Center, Leiden, The Netherlands

  2. 3

    Blood Transfusion Service of the Luxembourg Red Cross, Luxembourg

Author Information

  1. Intensive Care Medicine, Morriston Hospital, Swansea, Wales, UK

Publication History

  1. Published Online: 6 AUG 2012
  2. Published Print: 29 AUG 2012

ISBN Information

Print ISBN: 9780470655276

Online ISBN: 9781118338179

SEARCH

Keywords:

  • developments;
  • blood components, vigilance of alternatives;
  • risks and problems, identified by hemovigilance;
  • autologous blood transfusion techniques, POCS;
  • use of PAD;
  • collection of blood, no longer than four weeks prior to date of surgery;
  • AHH, requiring patient who can tolerate hypervolemia;
  • acute normovolemic hemodilution;
  • peri-operative cell salvage, ICS and post-operative cell salvage;
  • hemovigilance of alternatives

Summary

This chapter contains sections titled:

  • Introduction

  • Autologous blood transfusion techniques

  • Hemostatic fibrin sealants

  • Erythopoietin (EPO)

  • Aprotonin

  • Tranexamic acid

  • Recombinant VIIa

  • Hemovigilance of alternatives

  • References